Response of miRNA to treatment with Hypericum perforatum L. oil in multiple sclerosis
Acta Neurobiologiae Experimentalis · 2024
DOI: 10.55782/ane-2024-2571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, 2024. Verfasst von Huri Dedeakayogullari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry Department, Faculty of Medicine, Biruni University, Istanbul, Türkiye; Biruni University Research Center (B@MER), Biruni Univers…. Hauptthemen laut MEDLINE: MicroRNAs, Hypericum, Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
MicroRNA‑regulated gene expression plays an important role in autoimmune diseases, such as multiple sclerosis (MS). This study investigated the expression patterns of microRNAs (miRNAs) in MS in brain tissues using an animal experimental autoimmune encephalomyelitis (EAE) model treated with Hypericum perforatum (HP) oil. C57BL/6 J mice were divided into two groups: MS and control. The MS group was subdivided into sham (MS) and MS+HP. After the EAE induction treatment protocol, the patterns of miRNA expression profiles were determined in brain samples of the groups. The array data identified eleven miRNAs and candidate miRNA validation was performed by RT‑qPCR. A literature review of the validated miRNAs found that six of the eleven miRNAs (miR‑200a‑3p, miR‑200b‑3p, miR‑200c‑3p, miR‑182‑5p, miR‑183‑5p, and miR‑1298‑5p) were directly associated with MS. These miRNAs have been suggested as biomarkers of MS because they are highly correlated with the pathology of the disease. Furthermore, miRNA array analysis identified five candidate miRNAs (miR‑299a‑5p, miR‑206‑3p, miR‑325‑5p, miR‑10b‑5p, miR‑429‑3p) that are highly likely to be associated with MS pathogenesis, which could be helpful in the diagnosis and treatment of MS disease. This research offers vital insights that could be utilized in creating biomarkers and advancing treatments for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Biochemistry Department, Faculty of Medicine, Biruni University, Istanbul, Türkiye; Biruni University Research Center (B@MER), Biruni University, Istanbul, Türkiye.
- Department of Physiology, Faculty of Medicine, Gaziantep University of Science and Technology, Gaziantep, Türkiye.
- Medical Biochemistry Department, Faculty of Medicine, Biruni University, Istanbul, Türkiye.
- School of Medicine, Bezmialem Vakif University, Istanbul, Türkiye.
- Department of Physiology, School of Medicine, Bezmialem Vakif University, Istanbul, Türkiye.
- School of Medicine, Bezmialem Vakif University, Istanbul, T.
ORCID-Profile: Huri Dedeakayogullari
Zitieren
APA
Dedeakayogullari, H., Guleken, Z., Selek, S., Dogan, N., Yuce, B., Teloglu, E. S., Sonuc, G., Yildiz, C., Tiftik, E., Kilic, A., Yildizbas, B., & Bulut, Z. E. (2024). Response of miRNA to treatment with Hypericum perforatum L. oil in multiple sclerosis. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/ane-2024-2571
Vancouver
Dedeakayogullari H, Guleken Z, Selek S, Dogan N, Yuce B, Teloglu ES, et al. Response of miRNA to treatment with Hypericum perforatum L. oil in multiple sclerosis. Acta Neurobiologiae Experimentalis. 2024. doi:10.55782/ane-2024-2571
BibTeX
@article{Dedeakayogullari2024,
author = {Dedeakayogullari, Huri and Guleken, Zozan and Selek, Sahabettin and Dogan, Nur and Yuce, Busra and Teloglu, Emine Seyda and Sonuc, Gulreyhan and Yildiz, Cagla and Tiftik, Esra and Kilic, Aysu and Yildizbas, Beren and Bulut, Zeynep Ece},
title = {Response of miRNA to treatment with Hypericum perforatum L. oil in multiple sclerosis},
journal = {Acta Neurobiologiae Experimentalis},
year = {2024},
doi = {10.55782/ane-2024-2571}
}
EUVIMED